Guanghou Fu

9PUBLICATIONS
20CO-AUTHORS
Haematological tumoursCancer cell biologyMolecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Sep 16, 2024
Neoadjuvant everolimus in renal angiomyolipoma with or without tuberous sclerosis complex: Results from a multicenter, retrospective study.

Ruopeng Su, Tingxuan Huang, Liangyou Gu

|Sep 25, 2023
RCC1 functions as a tumor facilitator in clear cell renal cell carcinoma by dysregulating cell cycle, apoptosis, and EZH2 stability.

Yunfei Wu, Zhijie Xu, Xiaoyi Chen

|Sep 11, 2023
SETD2 Deficiency Confers Sensitivity to Dual Inhibition of DNA Methylation and PARP in Kidney Cancer.

Xinyi Zhou, Yohei Sekino, Hong-Tao Li

|Apr 28, 2023
Bioinformatics Prediction and Experimental Verification Identify CAB39L as a Diagnostic and Prognostic Biomarker of Kidney Renal Clear Cell Carcinoma.

Yunfei Wu, Zhijie Xu, Xiaoyi Chen

|Apr 13, 2023
POLD1 as a Prognostic Biomarker Correlated with Cell Proliferation and Immune Infiltration in Clear Cell Renal Cell Carcinoma.

Junjie Tian, Cheng Cheng, Jianguo Gao

|Feb 25, 2023
LINC00941 Promotes Cell Malignant Behavior and Is One of Five Costimulatory Molecule-Related lncRNAs That Predict Prognosis in Renal Clear Cell Carcinoma.

Huafeng Pan, Wei Wei, Guanghou Fu

Pageof 2

Frequent Collaborators

5 joint publications

Baiye Jin

2 joint publications

Baiye Jin

1 joint publications

Xinyi Zhou

1 joint publications

Yohei Sekino